$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

$esta Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000168875718000017 Filed on November 13, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q3
Revenue	$16.40M	$16.29M	$7.324M
YoY Change	38.87%	122.36%
Cost Of Revenue	$6.520M	$6.173M	$3.720M
YoY Change	24.19%	65.94%
Gross Profit	$9.870M	$10.11M	$3.604M
YoY Change	50.46%	180.6%
Gross Profit Margin	60.18%	62.1%	49.21%
Selling, General & Admin	$14.83M	$12.99M	$8.139M
YoY Change	70.26%	59.54%
% of Gross Profit	150.25%	128.4%	225.83%
Research & Development	$3.660M	$3.174M	$1.436M
YoY Change	50.0%	121.03%
% of Gross Profit	37.08%	31.39%	39.84%
Depreciation & Amortization	$770.0K	$21.00K	$550.0K
YoY Change	30.51%	-96.18%
% of Gross Profit	7.8%	0.21%	15.26%
Operating Expenses	$18.50M	$16.16M	$9.575M
YoY Change	65.92%	68.76%
Operating Profit	-$8.630M	-$6.046M	-$5.971M
YoY Change	88.02%	1.26%
Interest Expense	-$2.310M	$2.204M	$6.691M
YoY Change	10.0%	-67.06%
% of Operating Profit
Other Income/Expense, Net	$570.0K	-$1.274M	-$79.00K
YoY Change	-254.05%	1512.66%
Pretax Income	-$10.36M	$1.207M	-$10.64M
YoY Change	46.74%	-111.34%
Income Tax	$150.0K	-$99.00K	$31.00K
% Of Pretax Income		-8.2%
Net Earnings	-$10.51M	$1.306M	-$10.67M
YoY Change	47.41%	-112.24%
Net Earnings / Revenue	-64.09%	8.02%	-145.74%
Basic Earnings Per Share		$0.07	-$1.21
Diluted Earnings Per Share	-$515.4K	$0.06	-$1.21
COMMON SHARES
Basic Shares Outstanding	20.54M shares	19.15M shares	8.825M shares
Diluted Shares Outstanding		20.12M shares	8.825M shares

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$52.60M	$65.60M
YoY Change	382.57%
Cash & Equivalents	$52.64M	$65.58M	$4.671M
Short-Term Investments
Other Short-Term Assets	$4.300M	$5.600M
YoY Change	95.45%
Inventory	$24.85M	$15.37M
Prepaid Expenses
Receivables	$17.65M	$18.25M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$99.44M	$104.8M
YoY Change	152.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.91M	$12.89M
YoY Change	-4.35%
Goodwill	$465.0K	$465.0K
YoY Change	0.0%
Intangibles	$3.445M	$2.970M
YoY Change	1.29%
Long-Term Investments
YoY Change
Other Assets	$315.0K	$283.0K
YoY Change	15.81%
Total Long-Term Assets	$17.14M	$16.69M
YoY Change	-3.25%
TOTAL ASSETS
Total Short-Term Assets	$99.44M	$104.8M
Total Long-Term Assets	$17.14M	$16.69M
Total Assets	$116.6M	$121.5M
YoY Change	104.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.239M	$5.492M
YoY Change	-31.67%
Accrued Expenses	$6.125M	$5.861M
YoY Change	163.33%
Deferred Revenue	$908.0K
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$300.0K	$300.0K
YoY Change	0.0%
Total Short-Term Liabilities	$16.45M	$14.85M
YoY Change	-71.36%
LONG-TERM LIABILITIES
Long-Term Debt	$22.30M	$21.50M
YoY Change
Other Long-Term Liabilities	$3.551M	$3.431M
YoY Change	-24.01%
Total Long-Term Liabilities	$3.551M	$3.431M
YoY Change	-24.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.45M	$14.85M
Total Long-Term Liabilities	$3.551M	$3.431M
Total Liabilities	$47.09M	$44.49M
YoY Change	-24.18%
SHAREHOLDERS EQUITY
Retained Earnings	-$88.98M	-$78.46M
YoY Change	31.08%
Common Stock	$145.7M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.854M	$2.854M
YoY Change	-55.85%
Treasury Stock Shares	408.1K shares	408.1K shares
Shareholders Equity	$69.49M	$76.99M	-$3.249M
YoY Change
Total Liabilities & Shareholders Equity	$116.6M	$121.5M
YoY Change	104.17%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	-$10.51M	$1.306M	-$10.67M
YoY Change	47.41%	-112.24%
Depreciation, Depletion And Amortization	$770.0K	$21.00K	$550.0K
YoY Change	30.51%	-96.18%
Cash From Operating Activities	-$8.480M	-$10.50M	-$9.030M
YoY Change	4.18%	16.28%
INVESTING ACTIVITIES
Capital Expenditures	-$470.0K	-$570.0K	-$370.0K
YoY Change	-204.44%	54.05%
Acquisitions
YoY Change
Other Investing Activities	-$3.960M	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$4.430M	-$570.0K	-$370.0K
YoY Change	-1106.82%	54.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-60.00K	65.29M	13.24M
YoY Change	-100.44%	393.13%
NET CHANGE
Cash From Operating Activities	-8.480M	-10.50M	-9.030M
Cash From Investing Activities	-4.430M	-570.0K	-370.0K
Cash From Financing Activities	-60.00K	65.29M	13.24M
Net Change In Cash	-12.97M	54.22M	3.840M
YoY Change	-317.62%	1311.98%
FREE CASH FLOW
Cash From Operating Activities	-$8.480M	-$10.50M	-$9.030M
Capital Expenditures	-$470.0K	-$570.0K	-$370.0K
Free Cash Flow	-$8.010M	-$9.930M	-$8.660M
YoY Change	-6.75%	14.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001688757
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20538321	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Establishment Labs Holdings Inc.
	dei	Entity Small Business EntitySmallBusiness	false
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	15000000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27728000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1207000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	784000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5867000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2582000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3486000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3346000	USD
	esta	Deferred Offering Expense DeferredOfferingExpense	1468000	USD
	esta	Depreciationand Amortization Excluding Debt Discount Premium DepreciationandAmortizationExcludingDebtDiscountPremium	2041000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	546000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	13000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1549270	shares
CY2017Q3	esta	Allocated Sharebased Compensation Expense And Issuance Of Stock And Warrants For Services Or Claims AllocatedSharebasedCompensationExpenseAndIssuanceOfStockAndWarrantsForServicesOrClaims	568000	USD
	esta	Allocated Sharebased Compensation Expense And Issuance Of Stock And Warrants For Services Or Claims AllocatedSharebasedCompensationExpenseAndIssuanceOfStockAndWarrantsForServicesOrClaims	2390000	USD
CY2018Q3	esta	Allocated Sharebased Compensation Expense And Issuance Of Stock And Warrants For Services Or Claims AllocatedSharebasedCompensationExpenseAndIssuanceOfStockAndWarrantsForServicesOrClaims	2754000	USD
	esta	Allocated Sharebased Compensation Expense And Issuance Of Stock And Warrants For Services Or Claims AllocatedSharebasedCompensationExpenseAndIssuanceOfStockAndWarrantsForServicesOrClaims	4966000	USD
CY2018Q3	esta	Debt Instrument Equity Commitment DebtInstrumentEquityCommitment	2000000	USD
	esta	Debt Instrument Shares Offeredto Resell Ratio DebtInstrumentSharesOfferedtoResellRatio	0.5
	esta	Deferred Offering Expense DeferredOfferingExpense	0	USD
CY2017	esta	Deferred Offering Expense DeferredOfferingExpense	1600000	USD
CY2017Q3	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	400000	USD
	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	1100000	USD
CY2018Q3	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	500000	USD
	esta	Depreciation And Amortization Property Plant And Equipment DepreciationAndAmortizationPropertyPlantAndEquipment	1600000	USD
	esta	Depreciationand Amortization Excluding Debt Discount Premium DepreciationandAmortizationExcludingDebtDiscountPremium	1351000	USD
	esta	Employee And Non Employee Service Sharebased Compensation Nonvested Awards Compensation Cost Notyet Recognized Periodfor Recognition EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition	P3Y01M01D
CY2017Q3	esta	Initial Public Offering Expenses InitialPublicOfferingExpenses	0	USD
	esta	Initial Public Offering Expenses InitialPublicOfferingExpenses	1585000	USD
CY2018Q3	esta	Initial Public Offering Expenses InitialPublicOfferingExpenses	0	USD
	esta	Initial Public Offering Expenses InitialPublicOfferingExpenses	0	USD
CY2017Q4	esta	Line Of Credit Including Interest Payable Current LineOfCreditIncludingInterestPayableCurrent	19167000	USD
CY2018Q3	esta	Line Of Credit Including Interest Payable Current LineOfCreditIncludingInterestPayableCurrent	0	USD
	esta	Noncash Conversionof Related Party Convertible Notes Payable Into Ordinary Shares NoncashConversionofRelatedPartyConvertibleNotesPayableIntoOrdinaryShares	24252000	USD
	esta	Noncash Conversionof Related Party Convertible Notes Payable Into Ordinary Shares NoncashConversionofRelatedPartyConvertibleNotesPayableIntoOrdinaryShares	0	USD
CY2017Q3	esta	Noncash Warrant Extinguishmentof Warrants Related Party NoncashWarrantExtinguishmentofWarrantsRelatedParty	2400000	USD
	esta	Noncash Warrant Extinguishmentof Warrants Related Party NoncashWarrantExtinguishmentofWarrantsRelatedParty	958000	USD
	esta	Noncash Warrant Extinguishmentof Warrants Related Party NoncashWarrantExtinguishmentofWarrantsRelatedParty	0	USD
CY2017Q4	esta	Notes Payable Related Parties Including Interest Payable Current NotesPayableRelatedPartiesIncludingInterestPayableCurrent	4921000	USD
CY2018Q3	esta	Notes Payable Related Parties Including Interest Payable Current NotesPayableRelatedPartiesIncludingInterestPayableCurrent	0	USD
CY2018Q3	esta	Number Of Manufacturing Facilities NumberOfManufacturingFacilities	2	facility
	esta	Sharebased Compensation And Issuance Of Stock Or Warrants For Services And Claims SharebasedCompensationAndIssuanceOfStockOrWarrantsForServicesAndClaims	2390000	USD
	esta	Sharebased Compensation And Issuance Of Stock Or Warrants For Services And Claims SharebasedCompensationAndIssuanceOfStockOrWarrantsForServicesAndClaims	4966000	USD
	esta	Stock Issued During Period Shares Warrant Exercises StockIssuedDuringPeriodSharesWarrantExercises	31474	shares
CY2018Q3	esta	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	121000	USD
	esta	Write Offof Deferred Offering Expense WriteOffofDeferredOfferingExpense	1585000	USD
	esta	Write Offof Deferred Offering Expense WriteOffofDeferredOfferingExpense	0	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9131000	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	5492000	USD
CY2017Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	0	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13108000	USD
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18248000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2326000	USD
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5861000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3179000	USD
CY2018Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4637000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	76000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	799000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	963000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-191000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3133000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3811000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-96000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1969373	shares
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27986000	USD
CY2018Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	12891000	USD
CY2017Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2018Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	500000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	39382000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	104787000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1512000	USD
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1488000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6367000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2482000	USD
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	USD
CY2017	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2017Q4	us-gaap	Assets Assets	57095000	USD
CY2018Q3	us-gaap	Assets Assets	121472000	USD
CY2018Q3	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	694000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1446000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	754000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	645000	USD
CY2018Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	323000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	52000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	50000	USD
CY2018Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	422000	USD
CY2017Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	1300000	USD
CY2018Q3	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	1400000	USD
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	839000	USD
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	37000	USD
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	139000	USD
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	243000	USD
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	333000	USD
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	94000	USD
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	745000	USD
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	87000	USD
CY2017Q4	us-gaap	Cash Cash	10864000	USD
CY2018Q3	us-gaap	Cash Cash	65577000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	479000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4671000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10864000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65577000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4192000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	54713000	USD
CY2017Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2018Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.66
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	109447799	shares
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10723000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4420000	USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1685169	shares
CY2018Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3116521	shares
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27801000	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1506000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9861000	USD
CY2017Q3	us-gaap	Cost Of Revenue CostOfRevenue	3720000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	11731000	USD
CY2018Q3	us-gaap	Cost Of Revenue CostOfRevenue	6173000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	18566000	USD
CY2017Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	958000	USD
CY2018Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1500000	USD
CY2018Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	72000	USD
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.15
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.15
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.66
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-20000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-169000	USD
CY2018Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	3700000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	573000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1038000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	674000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	177000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	215000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	511000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	551000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	551000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2679000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3200000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	0	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-2102000	USD
CY2017Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	2095000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-2104000	USD
CY2018Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	11420000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	15945000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-76000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	465000	USD
CY2018Q3	us-gaap	Goodwill Goodwill	465000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2017	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	3604000	USD
	us-gaap	Gross Profit GrossProfit	11139000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	10113000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10521000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	89000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	31000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36000	USD
	us-gaap	Gross Profit GrossProfit	26245000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10643000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-99000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	63000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2460000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	70000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-6107000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3674000	USD
CY2017Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3974000	USD
CY2018Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	4008000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3401000	USD
CY2017Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	USD
CY2018Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	291000	USD
CY2018Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2970000	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	6691000	USD
	us-gaap	Interest Expense InterestExpense	8632000	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	2204000	USD
	us-gaap	Interest Expense InterestExpense	6548000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1567000	USD
	us-gaap	Interest Paid Net InterestPaidNet	3975000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10063000	USD
CY2018Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11972000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	13173000	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	15365000	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1978000	USD
CY2018Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	3333000	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1132000	USD
CY2018Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	60000	USD
CY2017Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	9000	USD
CY2018Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	5000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	9000	USD
CY2017Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	200000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	600000	USD
CY2018Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	700000	USD
CY2018Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P9Y
CY2017Q4	us-gaap	Liabilities Liabilities	62108000	USD
CY2018Q3	us-gaap	Liabilities Liabilities	44485000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57095000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	121472000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	57435000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	14851000	USD
CY2017Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	USD
CY2018Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	21486000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29332000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	81587000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1292000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1300000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23828000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-25405000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-10674000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-27764000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-6530000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-5360000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	1306000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-10584000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	9575000	USD
	us-gaap	Operating Expenses OperatingExpenses	41488000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5971000	USD
	us-gaap	Operating Expenses OperatingExpenses	26534000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	16159000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15395000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	884000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	938000	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	283000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-4999000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6046000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	851000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-15243000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	7783000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	823000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	4038000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	249000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	272000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-12091000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-49000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-37000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-6000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	529000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	200000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	723000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-49000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-37000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	200000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	723000	USD
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1228000	USD
CY2018Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3498000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4673000	USD
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3431000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-79000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-21000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1274000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3238000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4507000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	2400000	USD
	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	914000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	41000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1388000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1259000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2237000	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5597000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	28650000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1000000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	616000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	121000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16679000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1200000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2018Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	17529000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13500000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12892000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	650000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	25000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	138000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	226000	USD
CY2017Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	75000	USD
CY2018Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	75000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3174000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9026000	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	5083000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1436000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-67877000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-78461000	USD
CY2017Q3	us-gaap	Revenues Revenues	7324000	USD
	us-gaap	Revenues Revenues	22870000	USD
CY2018Q3	us-gaap	Revenues Revenues	16286000	USD
	us-gaap	Revenues Revenues	44811000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8139000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22114000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12985000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	32462000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2400000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	7.54
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	56101	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	778628	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.27
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4199000	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	19247000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	863932	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1460863	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.36
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.09
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	7900000	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	407126	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	4.81
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.91
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	16.15
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y7M17D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y11M16D
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	125596	shares
CY2017Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	24252000	USD
CY2018Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	USD
CY2017Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14723000	USD
CY2017Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3591000	USD
CY2017Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5527000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1610000	USD
CY2018Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14492000	USD
CY2018Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	70055000	USD
CY2017Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-8000	USD
CY2017Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	20000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	743000	USD
CY2018Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1470000	USD
CY2018Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2754000	USD
CY2017Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1122000	USD
CY2017Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	700000	USD
CY2017Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	568000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	436000	USD
CY2018Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2018Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	180000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	-15597000	USD
CY2017Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2854000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-26435000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	-22419000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	-3249000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-5013000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	-8760000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	2371000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	76987000	USD
CY2018Q3	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	0	USD
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1221210	shares
CY2018Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	408070	shares
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	6465000	USD
CY2018Q3	us-gaap	Treasury Stock Value TreasuryStockValue	2854000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-2104000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	15945000	USD
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8824807	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8824807	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20123297	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16146675	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8824807	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8824807	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19152995	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16146675	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Other Risks and Uncertainties</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#231f20;">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash, restricted cash and accounts receivable. The majority of the Company’s cash is held at one financial institution in the United States. The Company has not experienced any losses on its deposits of cash.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#231f20;">All of the Company’s revenue has been derived from sales of its products in international markets, principally Europe, Middle East, Latin America, and Asia. In the international markets in which the Company participates, the Company uses a combination of distributors and makes direct sales to customers. The Company performs ongoing credit evaluations of its distributors and customers, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During the </font><font style="font-family:Arial;font-size:10pt;">nine</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">September 30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;">, no customers accounted for more than 10% of the Company’s revenue. No customers accounted for more than 10% of the Company’s accounts receivable balance as of </font><font style="font-family:Arial;font-size:10pt;">September 30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;color:#231f20;">December 31, 2017</font><font style="font-family:Arial;font-size:10pt;">. Substantially all of the Company’s revenues are derived from the sale of Motiva Implants.</font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company relies on NuSil Technology, LLC, or NuSil, as the sole supplier of medical-grade silicone used in Motiva Implants as well as other products that are manufactured under contract to other customers. During the </font><font style="font-family:Arial;font-size:10pt;">nine</font><font style="font-family:Arial;font-size:10pt;"> months ended </font><font style="font-family:Arial;font-size:10pt;">September 30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;">, the Company had purchases of </font><font style="font-family:Arial;font-size:10pt;">$10.6 million</font><font style="font-family:Arial;font-size:10pt;">, or </font><font style="font-family:Arial;font-size:10pt;">64.9%</font><font style="font-family:Arial;font-size:10pt;"> of total purchases, and </font><font style="font-family:Arial;font-size:10pt;">$7.8 million</font><font style="font-family:Arial;font-size:10pt;">, or </font><font style="font-family:Arial;font-size:10pt;">39.0%</font><font style="font-family:Arial;font-size:10pt;"> of total purchases, respectively, from Nusil. As of </font><font style="font-family:Arial;font-size:10pt;">September 30, 2018</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;color:#231f20;">December 31, 2017</font><font style="font-family:Arial;font-size:10pt;">, we had an outstanding balance owed to this vendor of </font><font style="font-family:Arial;font-size:10pt;">zero</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$0.7 million</font><font style="font-family:Arial;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company’s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company’s future operating results and cause actual results to vary materially from expectations include, but are not limited to, uncertainty of regulatory approval of the Company’s current and potential future products, uncertainty of market acceptance of the Company’s products, competition from substitute products and larger companies, securing and protecting proprietary technology, strategic relationships and dependence on key individuals and sole source suppliers. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Products developed by the Company require clearances from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance that the products will receive the necessary clearances. If the Company was denied clearance, clearance was delayed, or the Company was unable to maintain its existing clearances, these developments could have a material adverse impact on the Company.</font></div></div>
	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Debt and Embedded Derivatives</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts. The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Debt with Conversion and Other Options.</font><font style="font-family:Arial;font-size:10pt;"> The Company records, when necessary, discounts to notes payable for the intrinsic value of conversion and other options embedded in debt instruments as a beneficial conversion option based upon the differences between the fair value of the underlying shares at the commitment date of the note transaction and the effective conversion price embedded in the note</font><font style="font-family:Arial;font-size:10pt;"> (see Note 6).</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company uses option pricing valuation models to determine the fair value of embedded derivatives and records any change in fair value as a component of other income or expense in the consolidated statements of operations</font><font style="font-family:Arial;font-size:10pt;"> (see Note 5).</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#231f20;">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant accounting </font><font style="font-family:Arial;font-size:10pt;">estimates and management judgments reflected in the consolidated condensed financial statements include items such as accounts receivable valuation and allowances, inventory valuation and allowances, valuation of acquired intangible assets, valuation of derivatives, estimation of assets’ useful lives and valuation of deferred income tax assets, including tax valuation allowances. Estimates are based</font><font style="font-family:Arial;font-size:10pt;color:#231f20;"> on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</font></div></div>

Files In Submission

Name	View Source	Status
0001688757-18-000017-index-headers.html	Edgar Link	pending
0001688757-18-000017-index.html	Edgar Link	pending
0001688757-18-000017.txt	Edgar Link	pending
0001688757-18-000017-xbrl.zip	Edgar Link	pending
esta-20180930.xml	Edgar Link	completed
esta-20180930.xsd	Edgar Link	pending
esta-20180930_cal.xml	Edgar Link	unprocessable
esta-20180930_def.xml	Edgar Link	unprocessable
esta-20180930_lab.xml	Edgar Link	unprocessable
esta-20180930_pre.xml	Edgar Link	unprocessable
establishmentlabs10q_2018q3.htm	Edgar Link	pending
exhibit311q32018.htm	Edgar Link	pending
exhibit312q32018.htm	Edgar Link	pending
exhibit321q32018.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

2018 Q4 Form 10-Q Financial Statement

#000168875718000017 Filed on November 13, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESTA ESTABLISHMENT LABS HOLDINGS INC. Stock $esta

2018 Q4 Form 10-Q Financial Statement

#000168875718000017 Filed on November 13, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ESTA
ESTABLISHMENT LABS HOLDINGS INC. Stock $esta